GPC
SGYP

Glacier Peak Capital’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Glacier Peak Capital’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-52,673
Closed -$153K – 34
2017
Q3 		$153K Buy
+52,673
New +$180K 0.17% 20

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Glacier Peak Capital's SGYP Position: Q4 2017 in Review

Glacier Peak Capital sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2017, closing a stake of 52,673 shares — an estimated $153K sold.

Glacier Peak Capital first reported a position in SGYP in Q3 2017 and held it in 1 quarter. The position peaked at $153K in Q3 2017. 150 funds tracked by Wall St. Rank hold SGYP as of Q4 2017.

  • Glacier Peak Capital reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2017 after selling out during the quarter.
  • Glacier Peak Capital sold 52,673 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2017, an estimated $153K.
  • Glacier Peak Capital first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2017 and held it in 1 quarter.
  • Glacier Peak Capital's Synergy Pharmaceuticals, Inc Common Stock position peaked at $153K in Q3 2017.
  • 150 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2017.

Based on Glacier Peak Capital's 13F filing for Q4 2017, filed 15 Feb 2018.